Astrocytes as a novel target in Alzheimer's disease

October 11, 2012

Alzheimer's disease is a severe neurodegenerative disease that affects 45% of people over 85 years of age. The research teams of Prof. Jin-Moo Lee at Washington University in Saint Louis, USA, and Prof. Milos Pekny at Sahlgrenska Academy in Gothenburg, Sweden, have identified astrocytes as a novel target for the development of future treatment strategies. The results have just been published in the FASEB Journal.

Astrocytes are known as cells that control many functions of the healthy as well as diseased brain, including the control of regenerative responses.

In patients suffering from Alzheimer's disease, astrocytes in the vicinity of and degenerating neurons become hyperactive.

Until now, many researchers considered this astrocyte hyperactivity in the brains of Alzheimer's disease patients as negative and contributing to the progression of this devastating disease.

The current study generated groundbreaking data with important implications. The US and Swedish research teams used a mouse model of Alzheimer's disease in which they genetically reduced astrocyte hyperactivity. They found that such mice developed more and showed more pronounced signs of neurodegeneration than mice with normal response of astrocytes.

This suggests that astrocyte response to the disease process slows down the disease progression.

"We are truly exited about these findings. Now we need to understand the mechanism underlying the beneficial role of hyperactive astrocytes in Alzheimer's disease progression. Understanding this process on a molecular level should help us to design strategies for optimization of the astrocyte response," says Prof. Milos Pekny.

"We see that astrocyte hyperactivity in Alzheimer's disease brains is tightly connected to activation of microglia, the brain's own . This implies that the two cell types communicate to mediate a coordinated response to disease states," says Prof. Jin-Moo Lee.

This international collaborative team of neuroscientists is pursuing further studies to understand molecular mechanisms by which astrocytes prevent the deposition of amyloid plaques in Alzheimer's disease.

Explore further: Astrocytes control the generation of new neurons from neural stem cells

More information: Andrew W. Kraft et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice, FASEB J fj.12-208660; published ahead of print October 4, 2012, doi:10.1096/fj.12-208660

Related Stories

Astrocytes control the generation of new neurons from neural stem cells

August 24, 2012
Astrocytes are cells that have many functions in the central nervous system, such as the control of neuronal synapses, blood flow, or the brain's response to neurotrauma or stroke.

Recommended for you

Canola oil linked to worsened memory and learning ability in Alzheimer's

December 7, 2017
Canola oil is one of the most widely consumed vegetable oils in the world, yet surprisingly little is known about its effects on health. Now, a new study published online December 7 in the journal Scientific Reports by researchers ...

Genetics study suggests that education reduces risk of Alzheimer's disease

December 7, 2017
The theory that education protects against Alzheimer's disease has been given further weight by new research from the University of Cambridge, funded by the European Union. The study is published today in the BMJ.

Healthy mitochondria could stop Alzheimer's

December 6, 2017
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called ...

Alzheimer's damage in mice reduced with compound that targets APOE gene

December 6, 2017
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

Lithium in water associated with slower rate of Alzheimer's disease deaths

December 5, 2017
Rates of diabetes and obesity, which are important risk factors for Alzheimer's disease, also decrease if there is a particular amount of lithium in the water, says the study, published recently in the Journal of Alzheimer's ...

Hyperbaric oxygen therapy may alleviate symptoms of Alzheimer's Disease

December 5, 2017
A new Tel Aviv University study reveals that hyperbaric oxygen treatments may ameliorate symptoms experienced by patients with Alzheimer's disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.